| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology, and The Alcohol Research and Treatment Center, Veterans Administration Medical Center, Bronx, and Mount Sinai School of Medicine, New York, New York 10029
Chronic ethanol ingestion in rats results in an increase in hepatic microsomal dimethylnitrosamine (DMN) demethylase activity and in an increase in hepatic microsomal activation of DMN to a mutagen. These effects of ethanol on DMN metabolism were detectable in vitro at DMN concentrations as low as 0.3 to 1 mM and as high as 100 mM. This ability of ethanol to increase the rate of DMN metabolism over such a broad range of DMN concentrations is in marked contrast to the effects of other microsomal enzyme inducers, such as phenobarbital and 3-methylcholanthrene, which increase the rate of DMN metabolism only at relatively high DMN concentrations and repress its metabolism at low DMN concentrations.
1 Supported by the Medical Research Service of the Veterans Administration; by USPHS Grants CA 22354, AA 03508, AA 00224, and AM 12511; and by American Cancer Society Grant BC 200A.
2 Recipient of a fellowship from the Deutsche Forschungsgemeinschaft.
Received 1/14/80. Accepted 9/22/80.
This article has been cited by other articles:
![]() |
L. Cancino-Badias, R.E. Reyes, R. Nosti, I. Perez, V. Dorado, S. Caballero, A. Soria, R. Camacho-Carranza, D. Escobar, and J.J. Espinosa-Aguirre Modulation of rat liver citochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods Mutagenesis, January 1, 2003; 18(1): 95 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Stickel, D Schuppan, E G Hahn, and H K Seitz Cocarcinogenic effects of alcohol in hepatocarcinogenesis Gut, July 1, 2002; 51(1): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mori, A. Koide, K. Fuwa, and Y. Kobayashi N-Benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays Mutagenesis, November 1, 2001; 16(6): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Escobar-Garcia, R. Camacho-Carranza, I. Perez, V. Dorado, M. Arriaga-Alba, and J.J. Espinosa-Aguirre S9 induction by the combined treatment with cyclohexanol and albendazole Mutagenesis, November 1, 2001; 16(6): 523 - 528. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |